The New England journal of medicine, 2020-10, Vol.383 (15), p.1413-1424
- Packer, Milton
- Anker, Stefan D
- Butler, Javed
- Filippatos, Gerasimos
- Pocock, Stuart J
- Carson, Peter
- Januzzi, James
- Verma, Subodh
- Tsutsui, Hiroyuki
- Brueckmann, Martina
- Jamal, Waheed
- Kimura, Karen
- Schnee, Janet
- Zeller, Cordula
- Cotton, Daniel
- Bocchi, Edimar
- Böhm, Michael
- Choi, Dong-Ju
- Chopra, Vijay
- Chuquiure, Eduardo
- Giannetti, Nadia
- Janssens, Stefan
- Zhang, Jian
- Gonzalez Juanatey, Jose R
- Kaul, Sanjay
- Brunner-La Rocca, Hans-Peter
- Merkely, Bela
- Nicholls, Stephen J
- Perrone, Sergio
- Pina, Ileana
- Ponikowski, Piotr
- Sattar, Naveed
- Senni, Michele
- Seronde, Marie-France
- Spinar, Jindrich
- Squire, Iain
- Taddei, Stefano
- Wanner, Christoph
- Zannad, Faiez
2020
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Packer, Milton
- Anker, Stefan D
- Butler, Javed
- Filippatos, Gerasimos
- Pocock, Stuart J
- Carson, Peter
- Januzzi, James
- Verma, Subodh
- Tsutsui, Hiroyuki
- Brueckmann, Martina
- Jamal, Waheed
- Kimura, Karen
- Schnee, Janet
- Zeller, Cordula
- Cotton, Daniel
- Bocchi, Edimar
- Böhm, Michael
- Choi, Dong-Ju
- Chopra, Vijay
- Chuquiure, Eduardo
- Giannetti, Nadia
- Janssens, Stefan
- Zhang, Jian
- Gonzalez Juanatey, Jose R
- Kaul, Sanjay
- Brunner-La Rocca, Hans-Peter
- Merkely, Bela
- Nicholls, Stephen J
- Perrone, Sergio
- Pina, Ileana
- Ponikowski, Piotr
- Sattar, Naveed
- Senni, Michele
- Seronde, Marie-France
- Spinar, Jindrich
- Squire, Iain
- Taddei, Stefano
- Wanner, Christoph
- Zannad, Faiez
- Titel
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- Ist Teil von
- The New England journal of medicine, 2020-10, Vol.383 (15), p.1413-1424
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2020
- Quelle
- EZB-FREE-00999 freely available EZB journals
- Beschreibungen/Notizen
- Among patients with heart failure and a reduced ejection fraction, those who received the SGLT2 inhibitor empagliflozin had a significantly lower incidence of cardiovascular death or hospitalization for heart failure than those who received placebo.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2022190Titel-ID: cdi_hal_primary_oai_HAL_hal_03733888v1
- Format
- –
- Schlagworte
- Aged, Antidiabetics, Benzhydryl Compounds - adverse effects, Benzhydryl Compounds - therapeutic use, Cardiology and cardiovascular system, Cardiovascular diseases, Cardiovascular Diseases - mortality, Cardiovascular Diseases - prevention & control, Congestive heart failure, Death, Diabetes, Diabetes mellitus, Diabetes Mellitus, Type 2 - complications, Disease Progression, Double-Blind Method, Drug dosages, Ejection fraction, Female, Genital tract, Glomerular filtration rate, Glomerular Filtration Rate - drug effects, Glucosides - adverse effects, Glucosides - therapeutic use, Heart failure, Heart Failure - complications, Heart Failure - drug therapy, Heart Failure - physiopathology, Hospitalization, Hospitalization - statistics & numerical data, Human health and pathology, Humans, Kidney diseases, Life Sciences, Male, Middle Aged, Peptides, Proportional Hazards Models, Quality of life, Renal Insufficiency, Chronic - complications, Sodium-glucose cotransporter, Sodium-Glucose Transporter 2 Inhibitors - adverse effects, Sodium-Glucose Transporter 2 Inhibitors - therapeutic use, Statistical analysis, Stroke Volume